Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Huber

Showing results (451-460 of 752) with videos related to

Pageof 76
Sort By:
Journal of the American College of Cardiology|March 22, 2023
Influence of Culprit Lesion Intervention on Outcomes in Infarct-Related Cardiogenic Shock With Cardiac ArrestUwe Zeymer, Brunilda Alushi, Marko Noc, et al.
Angiology|February 11, 2016
Intravenous Enoxaparin Versus Unfractionated Heparin in Elderly Patients Undergoing Primary Percutaneous Coronary Intervention: An Analysis of the Randomized ATOLL TrialZhenyu Liu, Johanne Silvain, Mathieu Kerneis, et al.
The Journal of Heart Valve Disease|March 26, 2015
Valvuloplasty with a paclitaxel-eluting balloon prevents restenosis in an experimental animal model of aortic stenosisKonstantinos Spargias, Mariann Gyöngyösi, Rayyan Hemetsberger, et al.
American Heart Journal|December 3, 2014
How can we optimize the processes of care for acute coronary syndromes to improve outcomes?Lars Wallentin, Steen Dalby Kristensen, Jeffrey L Anderson, et al.
JAMA Cardiology|November 9, 2017
Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical TrialRobert P Giugliano, Anthony Keech, Sabina A Murphy, et al.
International Journal of Cardiology|July 9, 2016
Endpoint design for future renal denervation trials - Novel implications for a new definition of treatment response to renal denervationThomas Lambert, Alexander Nahler, Miklos Rohla, et al.
European Heart Journal|May 3, 2014
Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process studyMartin Möckel, Julia Searle, Christian Hamm, et al.
European Heart Journal. Acute Cardiovascular Care|February 13, 2024
Current spectrum and outcomes of infarct-related cardiogenic shock: insights from the CULPRIT-SHOCK registry and randomized controlled trialUwe Zeymer, Tobias Heer, Taoufik Ouarrak, et al.
European Heart Journal. Acute Cardiovascular Care|March 26, 2024
European practices on antithrombotic management during percutaneous mechanical circulatory support in adults: a survey of the Association for Acute CardioVascular Care of the ESC and the European branch of the Extracorporeal Life Support OrganizationCharlotte J Van Edom, Justyna Swol, Thomas Castelein, et al.
American Heart Journal|December 3, 2014
Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?Kurt Huber, Eric R Bates, Marco Valgimigli, et al.
Pageof 76

Showing results (451-460 of 752) with videos related to

Sort By:
Pageof 76
Journal of the American College of Cardiology|March 22, 2023
Influence of Culprit Lesion Intervention on Outcomes in Infarct-Related Cardiogenic Shock With Cardiac ArrestUwe Zeymer, Brunilda Alushi, Marko Noc, et al.
Angiology|February 11, 2016
Intravenous Enoxaparin Versus Unfractionated Heparin in Elderly Patients Undergoing Primary Percutaneous Coronary Intervention: An Analysis of the Randomized ATOLL TrialZhenyu Liu, Johanne Silvain, Mathieu Kerneis, et al.
The Journal of Heart Valve Disease|March 26, 2015
Valvuloplasty with a paclitaxel-eluting balloon prevents restenosis in an experimental animal model of aortic stenosisKonstantinos Spargias, Mariann Gyöngyösi, Rayyan Hemetsberger, et al.
American Heart Journal|December 3, 2014
How can we optimize the processes of care for acute coronary syndromes to improve outcomes?Lars Wallentin, Steen Dalby Kristensen, Jeffrey L Anderson, et al.
JAMA Cardiology|November 9, 2017
Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical TrialRobert P Giugliano, Anthony Keech, Sabina A Murphy, et al.
International Journal of Cardiology|July 9, 2016
Endpoint design for future renal denervation trials - Novel implications for a new definition of treatment response to renal denervationThomas Lambert, Alexander Nahler, Miklos Rohla, et al.
European Heart Journal|May 3, 2014
Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process studyMartin Möckel, Julia Searle, Christian Hamm, et al.
European Heart Journal. Acute Cardiovascular Care|February 13, 2024
Current spectrum and outcomes of infarct-related cardiogenic shock: insights from the CULPRIT-SHOCK registry and randomized controlled trialUwe Zeymer, Tobias Heer, Taoufik Ouarrak, et al.
European Heart Journal. Acute Cardiovascular Care|March 26, 2024
European practices on antithrombotic management during percutaneous mechanical circulatory support in adults: a survey of the Association for Acute CardioVascular Care of the ESC and the European branch of the Extracorporeal Life Support OrganizationCharlotte J Van Edom, Justyna Swol, Thomas Castelein, et al.
American Heart Journal|December 3, 2014
Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?Kurt Huber, Eric R Bates, Marco Valgimigli, et al.
Pageof 76